Abstract
NKG2D is an activating receptor that is mostly expressed on cells of the cytotoxic arm of the immune system. Ligands of NKG2D are normally of low abundance, but can be induced in virtually any cell in response to stressors, such as infection and oncogenic transformation. Engagement of NKG2D stimulates the production of cytokines and cytotoxic molecules and traditionally this receptor is, therefore, viewed as a molecule that mediates direct responses against cellular threats. However, accumulating evidence indicates that this classical view is too narrow. During NK cell development, engagement of NKG2D has a long-term impact on the expression of NK cell receptors and their responsiveness to extracellular cues, suggesting a role in NK cell education. Upon chronic NKG2D engagement, both NK and T cells show reduced responsiveness of a number of activating receptors, demonstrating a role of NKG2D in induction of peripheral tolerance. The image that emerges is that NKG2D can mediate both inhibitory and activating signals, which depends on the intensity and duration of ligand engagement. In this review, we provide an overview of the impact of NKG2D stimulation during hematopoietic development and during acute and chronic stimulation in the periphery on responsiveness of other receptors than NKG2D. We propose that NKG2D interprets the context of the immunological environment through detection of cellular cues and in response sets the appropriate activation threshold for a large number of immune receptors. This perspective is of particular importance for future therapies that aim to exploit NKG2D signaling to fight tumors or infection.
Highlights
NKG2D, encoded by Klrk1, is an activating cell surface receptor that is predominantly expressed on cytotoxic immune cells
NKG2D-deficient mice display better NK cellmediated control of murine cytomegalovirus infection [33]. This effect seems specific for NKG2D, since deletion of CD16, another activating receptor expressed on all NK cells, does not affect CD16 independent NK cell function both in humans and in mice [37,38,39]
When NKG2D ligands are expressed chronically or at low intensity, for example during pregnancy in the placenta, they communicate a need for reduced receptor responsiveness and inhibit immune cell function
Summary
NKG2D, encoded by Klrk1, is an activating cell surface receptor that is predominantly expressed on cytotoxic immune cells. NKG2D-S is induced in activated NK cells, in which it promotes signaling through Syk/Zap70, resulting in enhanced cytotoxicity and cytokine production [17]. Both DAP10 and DAP12-mediated signaling is engaged upon NKG2D stimulation in activated murine NK cells [15].
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have